• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人骨髓造血祖细胞中端粒酶活性的差异表达。

Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow.

作者信息

Chiu C P, Dragowska W, Kim N W, Vaziri H, Yui J, Thomas T E, Harley C B, Lansdorp P M

机构信息

Geron Corporation, Menlo Park, California, USA.

出版信息

Stem Cells. 1996 Mar;14(2):239-48. doi: 10.1002/stem.140239.

DOI:10.1002/stem.140239
PMID:8991544
Abstract

The loss of telomeric DNA may serve as a mitotic clock which signals cell senescence and exit from cell cycle. Telomerase, and enzyme which synthesizes telomeric repeats de novo, is required to maintain telomere lengths. In humans, significant telomerase activity has been found in cells with essentially unlimited replicative potential such as reproductive cells in ovaries and testes, immortal cell lines and cancer tissues, but not in most normal somatic cells or tissues. We have now examined telomerase expression in subpopulations of hematopoietic cells from adult human bone marrow using a sensitive polymerase chain reaction-based telomeric repeat amplification protocol. Telomerase activity was found at low levels in the highly enriched primitive hematopoietic cells (CD34+CD71loCD45RAlo) and was increased transiently when these cells were cultured in the presence of a mixture of cytokines. In contrast, the early progenitors (CD34+CD71+) expressed telomerase activity at a higher level which was subsequently downregulated in response to cytokines. Telomerase activity remained low in the more mature CD34-cells upon exposure to cytokines. Taken together, our results suggest that telomerase is expressed at a basal level in all hematopoietic cell populations examined, is induced in a primitive subset of hematopoietic progenitor cells and is downregulated upon further proliferation and differentiation of these cells. We have previously observed telomere shortening in cytokine-stimulated primitive hematopoietic cells. The low and transient activation of telomerase activity described here thus appears insufficient to maintain telomere lengths in cultured hematopoietic cells.

摘要

端粒DNA的缺失可能充当有丝分裂时钟,发出细胞衰老和退出细胞周期的信号。端粒酶是一种能从头合成端粒重复序列的酶,对于维持端粒长度至关重要。在人类中,在具有基本无限复制潜能的细胞中发现了显著的端粒酶活性,如卵巢和睾丸中的生殖细胞、永生化细胞系和癌组织,但在大多数正常体细胞或组织中未发现。我们现在使用基于聚合酶链反应的敏感端粒重复序列扩增方案,检测了来自成人骨髓的造血细胞亚群中的端粒酶表达。在高度富集的原始造血细胞(CD34+CD71loCD45RAlo)中发现了低水平的端粒酶活性,当这些细胞在细胞因子混合物存在的情况下培养时,端粒酶活性会短暂增加。相比之下,早期祖细胞(CD34+CD71+)表达的端粒酶活性水平较高,随后在细胞因子的作用下被下调。暴露于细胞因子后,更成熟的CD34-细胞中的端粒酶活性仍然很低。综上所述,我们的结果表明,端粒酶在所检测的所有造血细胞群体中均以基础水平表达,在造血祖细胞的一个原始亚群中被诱导,并且在这些细胞进一步增殖和分化时被下调。我们之前观察到细胞因子刺激的原始造血细胞中端粒缩短。因此,这里描述的端粒酶活性的低水平和短暂激活似乎不足以维持培养的造血细胞中的端粒长度。

相似文献

1
Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow.成人骨髓造血祖细胞中端粒酶活性的差异表达。
Stem Cells. 1996 Mar;14(2):239-48. doi: 10.1002/stem.140239.
2
Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.急性和慢性白血病在体外培养前后的端粒酶活性和端粒长度
Cancer Res. 2000 Feb 1;60(3):610-7.
3
Effects of telomerase modulation in human hematopoietic progenitor cells.端粒酶调节对人造血祖细胞的影响。
Stem Cells. 2004;22(5):741-9. doi: 10.1634/stemcells.22-5-741.
4
Telomerase activity in human hematopoietic progenitor cells.人类造血祖细胞中的端粒酶活性
Haematologica. 1997 May-Jun;82(3):262-8.
5
Human CD34(+) and CD34(+)CD38(-) hematopoietic progenitors in sickle cell disease differ phenotypically and functionally from normal and suggest distinct subpopulations that generate F cells.镰状细胞病中的人类CD34(+)和CD34(+)CD38(-)造血祖细胞在表型和功能上与正常细胞不同,提示存在产生F细胞的不同亚群。
Exp Hematol. 2004 May;32(5):483-93. doi: 10.1016/j.exphem.2004.02.003.
6
Correlation between IL-3 receptor expression and growth potential of human CD34+ hematopoietic cells from different tissues.不同组织来源的人CD34+造血细胞中IL-3受体表达与生长潜能的相关性
Stem Cells. 1999;17(5):265-72. doi: 10.1002/stem.170265.
7
Impaired telomerase activity in uninfected haematopoietic progenitors in HIV-1-infected patients.HIV-1感染患者未感染造血祖细胞中端粒酶活性受损。
AIDS. 1998 Jun 18;12(9):999-1005.
8
Age-related decline in proliferative potential of purified stem cell candidates.纯化的干细胞候选物增殖潜能的年龄相关性下降。
Blood Cells. 1994;20(2-3):376-80; discussion 380-1.
9
Activation of telomerase in human lymphocytes and hematopoietic progenitor cells.人类淋巴细胞和造血祖细胞中端粒酶的激活。
J Immunol. 1995 Oct 15;155(8):3711-5.
10
Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34+ cells.细胞因子无反应性慢性粒细胞白血病骨髓CD34+细胞中BCR/ABL阴性造血祖细胞的体外优先隔离
Bone Marrow Transplant. 1997 Jun;19(12):1213-21. doi: 10.1038/sj.bmt.1700818.

引用本文的文献

1
Telomeres, telomerase, and cancer: mechanisms, biomarkers, and therapeutics.端粒、端粒酶与癌症:作用机制、生物标志物及治疗方法
Exp Hematol Oncol. 2025 Jan 27;14(1):8. doi: 10.1186/s40164-025-00597-9.
2
Transduction of Human Fetal Liver Hematopoietic CD34+ Stem and Progenitor Cells into a Cell Line by Enhancing Telomerase Activity.通过增强端粒酶活性将人胎儿肝脏造血CD34 +干细胞和祖细胞转导至细胞系中。
Int J Hematol Oncol Stem Cell Res. 2024 Oct 1;18(4):330-343. doi: 10.18502/ijhoscr.v18i4.16758.
3
Adaptive and Maladaptive Clonal Hematopoiesis in Telomere Biology Disorders.
端粒生物学障碍中的适应性和不适应性克隆性造血
Curr Hematol Malig Rep. 2024 Feb;19(1):35-44. doi: 10.1007/s11899-023-00719-2. Epub 2023 Dec 14.
4
An Identification and Characterization of the Axolotl () Telomerase Reverse Transcriptase (Amex TERT).墨西哥钝口螈端粒酶逆转录酶(Amex TERT)的鉴定与特性分析
Genes (Basel). 2022 Feb 18;13(2):373. doi: 10.3390/genes13020373.
5
Is There an Interconnection between Epithelial-Mesenchymal Transition (EMT) and Telomere Shortening in Aging?上皮-间质转化(EMT)与衰老过程中端粒缩短之间是否存在关联?
Int J Mol Sci. 2021 Apr 9;22(8):3888. doi: 10.3390/ijms22083888.
6
Molecular Mechanisms of Senescence and Implications for the Treatment of Myeloid Malignancies.衰老的分子机制及其对髓系恶性肿瘤治疗的意义
Cancers (Basel). 2021 Feb 4;13(4):612. doi: 10.3390/cancers13040612.
7
miR-615 Fine-Tunes Growth and Development and Has a Role in Cancer and in Neural Repair.miR-615 精细调节生长发育,在癌症和神经修复中发挥作用。
Cells. 2020 Jun 27;9(7):1566. doi: 10.3390/cells9071566.
8
Epigenome-wide association study of leukocyte telomere length.白细胞端粒长度的全表观基因组关联研究
Aging (Albany NY). 2019 Aug 26;11(16):5876-5894. doi: 10.18632/aging.102230.
9
is a transcriptional target of GATA1 and drives upregulation of telomerase activity in normal human erythroblasts.是 GATA1 的转录靶标,并驱动正常人类红细胞中端粒酶活性的上调。
Haematologica. 2020 Jun;105(6):1517-1526. doi: 10.3324/haematol.2018.215699. Epub 2019 Aug 14.
10
The Telomerase Complex Directly Controls Hematopoietic Stem Cell Differentiation and Senescence in an Induced Pluripotent Stem Cell Model of Telomeropathy.在端粒病的诱导多能干细胞模型中,端粒酶复合物直接控制造血干细胞的分化和衰老。
Front Genet. 2018 Aug 29;9:345. doi: 10.3389/fgene.2018.00345. eCollection 2018.